The data in the form of interview notes is available open access under the DOI: <https://doi.org/10.17037/DATA.00001403>.

Introduction {#sec005}
============

Globally, the latest estimates indicate that 295,000 maternal deaths occurred in 2017, 2.5 million newborns died in 2018, and 2.6 million stillbirths occurred in 2015. \[[@pone.0233969.ref001]--[@pone.0233969.ref003]\] Tackling this burden has been prioritised in national, regional and global actions, with ambitious targets set for maternal and newborn survival and well-being. \[[@pone.0233969.ref004], [@pone.0233969.ref005]\] A range of indicators are currently used at global, regional, national and sub-national levels to monitor the progress toward these goals, including the state of maternal and newborn health and well-being, as well as the health systems and care processes thought to influence health outcomes. Various maternal and newborn health initiatives have produced core indicator lists and a recent effort to map these various indicators found a rapidly expanding number of indicators numbering over 140. \[[@pone.0233969.ref006]\] Data sources, methods and definitions for estimating these indicators vary and change over time, and additional challenges exist with completeness, accuracy, transparency, and timeliness of available data.

For indicators to track progress, they must be measurable and clearly defined, accurate, reliable, valid, useful, relevant, accessible, specific, and time-bound. \[[@pone.0233969.ref007]\] The performance of indicators used for global monitoring along these dimensions is of crucial concern. Within the field of maternal and newborn health, work on measuring and improving validity of currently used indicators and indicators under development is a key part of this agenda. \[[@pone.0233969.ref008]--[@pone.0233969.ref011]\] Assessing the scientific robustness of indicators in the field of maternal and newborn health goes back several decades, along with development of measurement methods. More recently, several high-profile global efforts to identify and prioritise the most relevant maternal and newborn health indicators for consistent and up-to-date tracking of progress have resulted in additional research on indicator validity. \[[@pone.0233969.ref012], [@pone.0233969.ref013]\]

Given the amount of ongoing work to strengthen measurement for maternal and newborn health, increased coordination and harmonization of efforts are essential. \[[@pone.0233969.ref014]\] Maternal and newborn health are inextricably linked and it is important that measurement efforts address both maternal and newborn health, capture stillbirths, and other perinatal outcomes. In 2015, the World Health Organization (WHO) launched the Mother and Newborn Information for Tracking Outcomes and Results Technical Advisory Group (MoNITOR), which functions as a Technical Advisory body to the WHO on matters of measurement, metrics, and monitoring of maternal and newborn health for the Departments of Maternal, Newborn, Child and Adolescent Health and Reproductive Health and Research. \[[@pone.0233969.ref015], [@pone.0233969.ref016]\] The purpose of MoNITOR is to provide clear, independent, harmonized, and strategic advice for global and country stakeholders engaged in maternal and newborn health measurement and accountability. This paper is a result of research commissioned and chaired by the MoNITOR Secretariat to provide global guidance.

Objective {#sec006}
---------

The objective of this paper is to present a range of perspectives on how validity of maternal and newborn indicators is defined, understood, and measured by those who develop and use these indicators. We define validity as the level of scientific robustness of an indicator with respect to how well it captures a phenomenon or concept of interest. \[[@pone.0233969.ref017]\] We focus on the overall meaning of indicator validity, that is, the extent to which an indicator correctly measures an underlying maternal and newborn health phenomenon. \[[@pone.0233969.ref007], [@pone.0233969.ref018]\]

We do not aim address the topic of maternal and newborn indicator validity exhaustively; rather, we concentrate on identifying common conceptual and methodological themes and provide examples of different types of validation research approaches. We focus primarily on indicators related to the Sustainable Development Goals (SDGs), \[[@pone.0233969.ref005]\] the Global Strategy for Women\'s, Children\'s, and Adolescents\' Health, \[[@pone.0233969.ref019]\] Every Newborn Action Plan, \[[@pone.0233969.ref020]\] and Ending Preventable Maternal Mortality \[[@pone.0233969.ref021]\] and consider maternal and newborn health indicator validation work in countries of all income levels. However, examples are taken mainly from validation research in low- and middle-income country (LMIC) settings, as that is where the double burden of maternal and newborn morbidity and mortality as well as uncertainties regarding data quality concentrate. This framework is a part of a larger body of work led by MoNITOR to develop implementation support tools on 1. measuring validity of maternal and newborn health indicators; 2. prioritising indicators best suited for monitoring progress in various settings; 3. improving indicator usefulness and uptake by the various global and national stakeholders; and 4. identifying gaps that require additional research. These implementation support tools will also include an online tool to facilitate indicator use and interpretation.

Materials and methods {#sec007}
=====================

We were guided by principles for iterative development conceptual frameworks outlined by Jabareen. \[[@pone.0233969.ref022]\] They propose that a conceptual framework is based on multidisciplinary bodies of knowledge, and consist of "interlinked concepts that together provide a comprehensive understanding".

We iteratively moved between data collection and analysis, starting with mapping of data sources, analysis and categorisation of selected data, identification and naming of concepts (in light of the multidisciplinary literature on validity and reliability), and integration of concepts. Between December 2017 and April 2019, we used three data gathering approaches to develop this framework. We conducted interviews with key informants, a review of the published literature \[[@pone.0233969.ref023], [@pone.0233969.ref024]\], and a review of key indicator guidance documents, which were used to construct a framework of typologies of validation studies and provide examples of various types of indicator validation work. The validation phase of constructing this conceptual framework consisted of presentations and discussion of drafts of this framework during the May 2018, November 2018, and April 2019 meetings of MoNITOR and during several meetings with MoNITOR's co-chairs, whose feedback was incorporated in this document.

The full methods and results of the key informant interviews are reported in a separate paper. \[[@pone.0233969.ref025]\] We used purposive sampling to identify key informants until thematic saturation was achieved. First, AM, A-BM and LB drew up a list of potential key informants through discussion and with input from the MoNITOR co-chairs. The list was further expanded using snowball methods to encompass qualitative and quantitative measurement experts on the various types of maternal and newborn indicators (health system and input, care access and availability, quality of care and safety, coverage and outcomes, and health impact). The final sample of 32 key informants interviewed included 22 measurement experts based in academic institutions, four from funders operating in the space of maternal and newborn health, two from United Nations agencies, two from implementing agencies, and two from data collection organisations.

We used a semi-structured interview guide, pre-tested on the first five informants, covering five themes: the meaning of indicator validity, methodological approaches to assessing validity, acceptable levels of indicator validity, gaps in validation research, and recommendations for addressing these gaps. Interviews (six in person and 25 by phone/Skype) were conducted by LB in English between December 2017 and November 2018 and ranged between 45 and 90 minutes. Detailed notes were taken in shorthand during the interviews, and were transcribed and expanded immediately following the interview. Several key informants sent additional written materials (reports, unpublished manuscripts) and publications following their interview. These were included in the literature review if relevant to the study. We used the thematic content approach to analyze the interview notes and identify themes through a coding framework using a mix of deductive and inductive codes. No ethics approval was sought. All key informants were asked to review their interview notes and agreed to have their anonymized interview notes included in an open access data file. \[[@pone.0233969.ref026]\]

We reviewed the literature with a focus on identifying a range of study designs relevant to indicator validation within the field of maternal and newborn health. We used a combination of text and MeSH terms related to the concepts of 1. validity (validation, validity, reliability, sensitivity, specificity, verification, concordance, area under the curve, receiver operating curve), 2. maternal and newborn health (maternal, pregnancy, antenatal, childbirth, peripartum, intrapartum, labour, newborn, neonatal, postpartum, postnatal, perinatal, obstetric, stillbirth), and 3. indicators (indicator, estimate) and searched Medline, Embase, and Global Health databases on March 16, 2018 for English language articles published since 1990. Further, we used key informant recommendations of publications and reports to complement the search results. We screened the titles and abstracts of identified references (10,974 from Medline, 14,696 from Embase, 2,476 from Global Health, and 53 received from key informants). We included 119 references in full-text and used these in the development of the conceptual framework or as examples of validation studies. Last, we reviewed 12 key indicator guidance documents relevant to maternal and newborn health. \[[@pone.0233969.ref006], [@pone.0233969.ref008], [@pone.0233969.ref027]--[@pone.0233969.ref036]\]

Definitions {#sec008}
-----------

An indicator is a quantifiable characteristic of a defined population which has a standard definition. \[[@pone.0233969.ref035], [@pone.0233969.ref036]\] We limit our consideration to indicators related to the health status and the health care of women and newborns during pregnancy, childbirth and the postnatal period. We aimed to synthesise the various perspectives on understanding and assessing validity of maternal and newborn health indicators obtained from the literature and key informant interviews and to characterise these approaches using a common language to aid efforts to achieve standard measurement language. To help characterize the various approaches used to assess validity of maternal and newborn health indicators, we classified the key types of maternal and newborn health indicators currently in use. For the purpose of this paper, we categorize indicators ([Fig 1](#pone.0233969.g001){ref-type="fig"}) using a framework adapted from Moller and colleagues \[[@pone.0233969.ref006]\] into the following key domains of maternal and newborn health indicators:

1.  Health system--includes human and financial resources, policies, guidelines, mechanisms, and information flows.

2.  Access to and availability of care---refers to accessibility of care to users, availability of health facilities, services and essential supplies and equipment.

3.  Care coverage---indicators of the extent to which care is used (e.g. antenatal care and newborn care).

4.  Care content and quality---includes care content (elements of care delivered as part of care processes) and person-centeredness of care.

5.  Impact--refers to the long-term effects on health status, including morbidity and mortality.

![Key domains of maternal and newborn health indicators.](pone.0233969.g001){#pone.0233969.g001}

An appraisal of an indicator's validity requires theoretical clarity about the concept that the indicator is intended to measure, and should be done in conjunction with an assessment of its reliability, and potentially also the feasibility of its production. Reliability, a key concept closely related to validity, captures the extent to which results are repeatable; in other words, how well the method is able to achieve similar measurement over repeated efforts. \[[@pone.0233969.ref036], [@pone.0233969.ref037]\] Studies in the field of maternal and newborn indicators assessing reliability also use the terms consistency, agreement, and concordance; studies assessing reliability of measures over time also use the terms decay/deterioration (of recall), and repeatability.

The four scenarios of the combination of high/low criterion validity and reliability of a measurement are visualised in [Fig 2](#pone.0233969.g002){ref-type="fig"}. The center of the bullseye represents the truth or the gold standard against which criterion validity is assessed while the dots represent data points. \[[@pone.0233969.ref038]\] As can be seen in the scenarios, consistent (reliable) indicator measurement may or may not be accurately capturing the "truth" or gold standard, while consistently valid measurement (hitting the bullseye) may still result in broad variations in estimates (limited reliability). The possibility of an indicator measurement having relatively low reliability yet still being valid differs from the perspective of other social science disciplines; it is a result of a situation where measurement is not precise on an individual level, but without systematic bias, and this produces estimates close to the truth on a population level (captured, for example, by inflation factor). \[[@pone.0233969.ref039]--[@pone.0233969.ref042]\]

![Visual representation of criterion validity and reliability of measurement.](pone.0233969.g002){#pone.0233969.g002}

Results {#sec009}
=======

Three main types of validity of maternal and newborn health indicators were identified from the existing literature and key informant interviews ([S1 Table](#pone.0233969.s001){ref-type="supplementary-material"}). These types broadly map onto the social science definitions of criterion, convergent, and construct validity. [Fig 3](#pone.0233969.g003){ref-type="fig"} shows an example of the three types of validity in relation to one construct and two potential indicators measuring this construct. We describe each type of indicator validity in detail, giving examples of indicators and published studies, with a focus on approaches and measurement methods used to assess validity.

a.  [Criterion validity]{.ul}: Assessment of criterion validity, also referred to as diagnostic validity, examines whether the operationalization or measurement of a construct behaves as expected. A common way to examine criterion validity is to compare a measurement with a "gold-standard" or reference standard.

b.  [Convergent validity]{.ul}: Assessments of convergent validity examine the extent to which one measurement is similar to (converges with) other measurements to which it should be related, based on a common underlying construct (i.e. assessment of different methods of capturing the same construct). The main difference between criterion and convergent validity is that for the second, no gold standard measurement is available, which is why new or indirect measures are sometimes referred to as surrogate or proxy indicators. Assessments of convergent validity in maternal and newborn health have compared two or more indicators, or two or more measurement methods to estimate one indicator ([Fig 3](#pone.0233969.g003){ref-type="fig"}).

c.  [Construct validity]{.ul}: An assessment of construct validity examines whether a given operalization (through indicator definition and its measurement) accurately reflects the phenomenon it is intended to measure. Construct validity is an umbrella term which subsumes all other types of validity, and therefore available assessments of criterion, convergent and other types of validity should be taken into consideration when evaluating the overall level of construct validity of an indicator.

![Example of the three types of validity in maternal and newborn health indicators.](pone.0233969.g003){#pone.0233969.g003}

Criterion validity {#sec010}
------------------

Studies of maternal and newborn health indicators assessing criterion validity seek to understand the accuracy of a method of measurement compared to a "gold" or reference standard. Assessments of criterion validity measure the extent to which a current or proposed method of generating an estimate of an indicator accurately reflects an objective truth. Several key informants suggested that criterion validity, meaning the comparison of a measurement method to a gold standard, is perhaps the most commonly shared understanding of validity among the various stakeholders in the maternal and newborn health field. However, they also acknowledged that it captures the narrowest, most technical, aspect of indicator validity. Within maternal and newborn health, studies of criterion validity have predominantly assessed concurrent rather than predictive validity. The focus of criterion validity assessments has been largely on indicators of care coverage and content and to some extent on impact indicators. Examples of studies assessing criterion validity of maternal and newborn health indicators are shown in [Table 1](#pone.0233969.t001){ref-type="table"}.

10.1371/journal.pone.0233969.t001

###### Examples of studies assessing criterion validity.

![](pone.0233969.t001){#pone.0233969.t001g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Indicator domain                                                                                                                                                                             Examples of studies (reference standard and setting)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------
  **Care coverage**                                                                                                                                                                            Women's self-report compared to:\
                                                                                                                                                                                               • Observations during antenatal, intrapartum and postnatal care from\
                                                                                                                                                                                                   ○ Hospitals in Kenya \[[@pone.0233969.ref040], [@pone.0233969.ref043]\],\
                                                                                                                                                                                                   ○ Health facilities in Mozambique \[[@pone.0233969.ref044]\].\
                                                                                                                                                                                               Women's self-report compared to:\
                                                                                                                                                                                               • Medical records from medical booklets and HMIS: China through population-based survey \[[@pone.0233969.ref045]\].

  Coverage of maternal and newborn care interventions, skilled provider at birth, caesarean section rate                                                                                       

  **Care content and quality**                                                                                                                                                                 Women's self-report compared to:\
                                                                                                                                                                                               • Observations of care in hospitals in Tanzania, Bangladesh, Nepal \[[@pone.0233969.ref046]\]\
                                                                                                                                                                                               • Medical records/facility registers in hospitals in Tanzania, Bangladesh, Nepal \[[@pone.0233969.ref046]\].

  Immediate initiation of breastfeeding, newborn resuscitation                                                                                                                                 

  **Impact**                                                                                                                                                                                   Women's self-report compared to:\
                                                                                                                                                                                               • Biomarkers and/or medical diagnoses as captured in clinical notes in samples drawn from:\
                                                                                                                                                                                                   ○ Indonesian hospitals \[[@pone.0233969.ref047]\],\
                                                                                                                                                                                                   ○ Ghana hospital \[[@pone.0233969.ref048]\],\
                                                                                                                                                                                                   ○ A tertiary hospital in Brazil \[[@pone.0233969.ref049]\],\
                                                                                                                                                                                                   ○ Maternity hospitals in Bolivia \[[@pone.0233969.ref050]\].\
                                                                                                                                                                                               Women's self-report compared to:\
                                                                                                                                                                                               • Clinical examination findings from a community survey in Egypt \[[@pone.0233969.ref051]\].

  Prevalence of maternal morbidities or obstetric complications (e.g. haemorrhage, pre-eclampsia/eclampsia, labour dystocia, prolapse), prevalence of severe maternal morbidity or near miss   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Many key informants noted that a substantial portion of recent work on assessing criterion validity has focused on indicators of care coverage and content captured in household surveys such as the Demographic Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS). \[[@pone.0233969.ref052], [@pone.0233969.ref053]\] Munos and colleagues discuss many considerations and elements of diagnostic-style (criterion) validity studies related to assessing the validity of care coverage indicators based on data from population-level surveys. \[[@pone.0233969.ref042]\] A common approach to assessing validity of women's recall of specific events or care content is to compare women's recall (captured during an exit interview or sometime later during a home visit) against a "gold standard" based on direct observations of care or, less commonly, care elements documented in a facility register or patient record. The most important quantitative metrics used by assessments of criterion validity are summarised in [Table 2](#pone.0233969.t002){ref-type="table"}.

10.1371/journal.pone.0233969.t002

###### Commonly used measures of criterion validity (adapted from \[[@pone.0233969.ref042], [@pone.0233969.ref054]\]).

![](pone.0233969.t002){#pone.0233969.t002g}

  Measure                                                                                                                              Definition, calculation, meaning
  ------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Individual-level validity**                                                                                                        
  Sensitivity                                                                                                                          The percentage of individuals with the outcome/characteristic of interest who were correctly classified as such.
  Specificity                                                                                                                          The percentage of individuals without the outcome/characteristic of interest correctly classified as such.
  Percent agreement or Accuracy                                                                                                        The percentage of individuals who were correctly classified, i.e. for whom the outcome/characteristic of interest being measured is a match to the gold-standard comparison.
  Positive predictive value                                                                                                            The probability that an individual who reported having an outcome/characteristic of interest truly had it.
  Negative predictive value                                                                                                            The probability that an individual who did not report having an outcome/characteristic of interest truly did not have it.
  Area under the receiver operating characteristic curve (AUC)                                                                         Plot of sensitivity versus 1-specificity. A value of 1 means a perfect match, 0.5 a random guess. For binary measures, this is the average of sensitivity and specificity.
  Other, less commonly used, measures include likelihood ratio \[[@pone.0233969.ref049]\] and efficiency \[[@pone.0233969.ref048]\].   
  **Population-level validity**                                                                                                        
  Inflation factor (IF) or Test to Actual Positive (TAP) ratio                                                                         Ratio of the population prevalence based on the measure being assessed in comparison with the true prevalence based on the gold standard. \[[@pone.0233969.ref055]\] This measure expresses the extent to which the true population prevalence of the indicator is under- or over-estimated, given the sensitivity and specificity of the measure under consideration and the true population prevalence. It is possible for an indicator to show low individual-level accuracy but good population-level accuracy.

Some of the limitations of these predominantly facility-based criterion validity studies include limited generalisability, additional assumptions required to assess the extent of bias affecting population-level estimates, and issues with high coverage of routine care elements, which lead to sample sizes too small to calculate specificity. In addition, maternal and newborn health indicators based on population-level surveys have a two- to five-year recall period. Indicator validity is dependent on the ability of women to recall an event, which may be affected by length of time since the event. Only a few studies have assessed criterion validity based on length of the recall period since pregnancy and childbirth; many report substantial issues in the ability to ensure high follow-up rates and found some deterioration in the accuracy of women's recall as the length of recall period increases. \[[@pone.0233969.ref043], [@pone.0233969.ref044], [@pone.0233969.ref047], [@pone.0233969.ref049]\]

Despite the numerous metrics to statistically assess criterion validity, there is no consensus on what thresholds indicate acceptable or good indicator validity levels. Key informants agreed that there is no objective or recommended cut-off point for a "good" level of diagnostic validity that could single-handedly inform a recommendation to endorse the use of an indicator. Such endorsement would rely on crucial additional considerations, such as the intended use of the proposed indicator, quality of the data and its source(s), and quality of the gold standard used to assess validity. One key informant commented that "acceptable validity depends on how much imperfection you are willing to put up with and what purpose is the information for".

We present examples of pre-specified cut-offs provided by studies assessing validity of indicators based on women's recall ([Table 3](#pone.0233969.t003){ref-type="table"}). It is important to note that most studies focus solely on assessing validity of indicator numerators. The validity of an indicator's denominator also has implications for the validity of the overall indicator, but has been less commonly evaluated. This is particularly important for indicators where the denominator is the population in need of an intervention. Decades of work to try to define the need for caesarean section as a denominator for a caesarean section rate indicator (including setting benchmark levels of caesarean section rates for all births irrespective of need used as a denominator) have led to the conclusion that the population of women in need of a caesarean section must be defined locally based on the epidemiological profile and context. \[[@pone.0233969.ref056], [@pone.0233969.ref057]\] Similarly, ongoing work to define appropriate denominators of newborns in need of targeted interventions such as resuscitation face a similar challenge since the population of newborns in need of resuscitation may vary based on different context and settings, e.g. be higher in referral compared to primary facilities. \[[@pone.0233969.ref058]\]

10.1371/journal.pone.0233969.t003

###### Examples of pre-specified acceptable validity levels.

![](pone.0233969.t003){#pone.0233969.t003g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source                                                                                          Indicator types                                                                                                                               Metric and Level
  ----------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Ronsmans 1996 \[[@pone.0233969.ref054]\]                                                        Maternal morbidity, obstetric complications                                                                                                   Fairly accurate if sensitivity and specificity \>80%; high specificity is very important for rare outcomes to limit over-reporting of actual prevalence

  Liu et al. 2013 \[[@pone.0233969.ref045]\]                                                      Coverage and content of antenatal, delivery and postnatal care                                                                                Sensitivity/specificity:\
                                                                                                                                                                                                                                                • Low \<0.33\
                                                                                                                                                                                                                                                • Moderate 0.33--0.66\
                                                                                                                                                                                                                                                • High \>0.66\
                                                                                                                                                                                                                                                AUC--overall validity "high" if AUC\>0.67 (otherwise moderate/low)\
                                                                                                                                                                                                                                                Population-level bias\
                                                                                                                                                                                                                                                • Small if 0.8\<TAP ratio\<1.2\
                                                                                                                                                                                                                                                • Moderate 0.5\<TAP ratio\<1.5\
                                                                                                                                                                                                                                                • Large \<0.5 TAP ratio \>1.5

  Stanton et al. 2013 \[[@pone.0233969.ref044]\]                                                  Maternal and newborn health interventions during peripartum period in health facilities                                                       Acceptable if\
                                                                                                                                                                                                                                                AUC\>0.60 or IF 0.75--1.25\
                                                                                                                                                                                                                                                (Suggest indicators warranting incorporation into population-level surveys should meet both criteria- individual and population level validity)

  Blanc et al. 2016 \[[@pone.0233969.ref040]\], McCarthy et al. 2016 \[[@pone.0233969.ref043]\]   Quality of maternal and newborn health care during childbirth                                                                                 Individual-level accuracy measured by AUC\
                                                                                                                                                                                                                                                • High: AUC\>0.7\
                                                                                                                                                                                                                                                • Moderate: 0.6\<AUC\<0.7\
                                                                                                                                                                                                                                                • Low: AUC\<0.6\
                                                                                                                                                                                                                                                Degree of bias measured by IF\
                                                                                                                                                                                                                                                • Low 0.75\<IF\<1.25\
                                                                                                                                                                                                                                                • Moderate 0.5\<IF\<1.5\
                                                                                                                                                                                                                                                • Large IF\<0.5 \| IF\>1.5\
                                                                                                                                                                                                                                                High overall performance: high AUC + low IF\
                                                                                                                                                                                                                                                Reliability (decay in accuracy between baseline taken during exit interview and at 13--15 months post delivery)--Phi coefficient (r~phi~)\
                                                                                                                                                                                                                                                • Poor if \<0.4, Moderate between 0.4 and 0.6; High 0.6--0.8; \> = 0.8 almost perfect agreement.

  Blanc et al. 2016 \[[@pone.0233969.ref060]\]                                                    Skilled birth attendant and key elements of maternal, intrapartum, newborn and immediate postnatal care among women with vaginal deliveries   Benchmarks of validity:\
                                                                                                                                                                                                                                                • AUC\> = 0.6\
                                                                                                                                                                                                                                                • 0.75\<IF\<1.25\
                                                                                                                                                                                                                                                Overall acceptable indicator performance: both AUC and IF benchmarks met

  Munos et al. \[[@pone.0233969.ref042]\], Chang et al. 2018 \[[@pone.0233969.ref061]\]           Coverage indicators                                                                                                                           AUC≥0.70

  IF 0.75--1.25                                                                                                                                                                                                                                 

  (study authors acknowledge these are arbitrary)                                                                                                                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AUC: Area under the receiver operating characteristic curve; TAP: test to actual positive ratio; IF: inflation factor.

Key informants also highlighted the recent development and use of new indicators, such as those capturing maternal and newborn health financing, policies, and health system aspects. For health systems indicators, the validity of indicators capturing the existence of specific policies is sometimes referred to as "verification". Methods for such research might include a Ministry of Health representative reporting on policies, compared to the "gold standard" of policy existence as a ratified document, assessed through a document review. \[[@pone.0233969.ref059]\] Existence of a policy, however, does not guarantee its rollout or implementation, merely its existence.

Convergent validity {#sec011}
-------------------

The second common type of indicator validity assessment we identified in the literature compares estimates from various data sources or measurement approaches seeking to measure the same construct to understand the convergence between them ([Fig 3](#pone.0233969.g003){ref-type="fig"}). Studies assessing convergent validity, also referred to as "triangulation\" by several key informants, aim to quantify the extent to which two or more estimates which should be related because they converge on the same theoretical construct, are in fact related. Assessments of convergent validity are commonly used in situations where a "gold standard" does not exist or is infeasible to estimate. A typical question asked in assessments of convergent validity is the extent to which a new/different data source or estimation method compares to an established source or method. Studies also seek to understand the strengths and limitations, including financial feasibility, of the measurement approaches being compared. A wide range of methods has been used to examine the extent of agreement between distinct measurement methods and data sources used to calculate an indicator, including whether the data is on an individual, cluster (e.g. region, facility), or population level. Similarly to criterion validity, the cut-off point for an acceptable level of convergent validity is also subjective. Examples of studies assessing convergent validity are shown in [Table 4](#pone.0233969.t004){ref-type="table"}. We did not identify studies of discriminant validity (assessments of the extent to which an indicator is not associated with indicators or constructs it should not be associated with).

10.1371/journal.pone.0233969.t004

###### Examples of approaches to assess convergent validity.
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  Indicator                                                             Estimation method 1                                                                                                                                                                                                Estimation method 2                                    Comparison
  --------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------ ----------------------------------------------------------------
  Stillbirth rate, neonatal mortality rate \[[@pone.0233969.ref062]\]   Full history of all live births and questions on pregnancies in the last five years resulting in non-live births                                                                                                   Full history of all pregnancies and their outcomes     Crude and adjusted risk ratios (determinants and clustering)
  Maternal and perinatal mortality \[[@pone.0233969.ref063]\]           Enhanced community-level surveillance system                                                                                                                                                                       Routine data                                           Comparison of rate/ratios
  Postnatal care coverage \[[@pone.0233969.ref064]\]                    DHS questions                                                                                                                                                                                                      MICS questions                                         Descriptive comparison of proportions and timing
  Caesarean section rate \[[@pone.0233969.ref065]\]                     Population-based survey (DHS, MICS)                                                                                                                                                                                Health facility records                                Linear regression coefficient; confidence interval overlap
  Antenatal care coverage and content \[[@pone.0233969.ref066]\]        Individual-level data from clinical records weighted to population level                                                                                                                                           Aggregate routine health information systems reports   Simple comparisons of proportions and 95% confidence intervals
  Estimates of value of aid for RMNCAH \[[@pone.0233969.ref067]\]       Comparison of estimates from four initiatives: Countdown to 2015, the Institute for Health Metrics and Evaluation, the Muskoka Initiative, and the Organisation for Economic Co-operation and Development (OECD)   Simple differences                                     

DHS---Demographic Health Surveys, MICS---Multiple Indicator Cluster Surveys, RMNCAH--Reproductive, maternal, newborn, child and adolescent health.

Construct validity {#sec012}
------------------

One of the most important types of indicator validity highlighted in key informant interviews was construct validity. An indicator provides a simplified way of capturing a more complex phenomenon. Construct validity can be defined as the accuracy of the operationalisation of such phenomenon, and thus assesses the extent to which inferences can be made from the operationalization of an indicator to the theoretical construct which those operationalizations were intending to reflect. \[[@pone.0233969.ref068]\] In other words, the question is not how valid an indicator is, but how valid is this specific measurement of an indicator, in this place, at this time. In regard to indicator construct validity Arnold and Khan call this process of transforming concepts into indicators and further into survey questions the "validity of question". \[[@pone.0233969.ref069]\] The purpose of an indicator is central to assessing construct validity as well as other types of validity, \[[@pone.0233969.ref070]\] or, as noted by Etches and colleagues, "\[a\] concept-driven selection process should result in more methodologically sound indicators." \[[@pone.0233969.ref071]\]

The importance of clearly understanding and articulating an indicator's purpose was highlighted in a recent paper by Radovich and colleagues that examined the indicator capturing the percentage of births occurring with the assistance of a skilled birth attendant (SBA). \[[@pone.0233969.ref072]\] Several respondents emphasized that the process of assessing whether an indicator is "valid" should start with an understanding of not only the construct or phenomenon an indicator intends to measure, but also for whom and why. This includes a consideration of whether the underlying phenomenon itself is meaningful, that is, whether its purpose is important to maternal and newborn health and clearly understood by all stakeholders ([S1 Table](#pone.0233969.s001){ref-type="supplementary-material"}). A rigorous and complete assessment of construct validity must include both theoretical and empirical approaches, ideally involving the users of indicators for decision-making in the various global settings. \[[@pone.0233969.ref073]\] Yet, despite the importance attributed to construct validity by key informants, there was comparatively little published literature within maternal and newborn health focusing on this topic.

Some of the key indicators currently in use in the field of maternal and newborn health were developed, or are being used, as proxies for constructs that are considered important by stakeholders but are not feasible or possible to measure simply or directly. This relates to, for example, maternal mortality (large sample sizes required means measurement is expensive) \[[@pone.0233969.ref074]--[@pone.0233969.ref076]\] and quality of care (a multi-dimensional construct requiring data on technical and clinical levels as well as patient's experience). \[[@pone.0233969.ref077]\] In particular, many key informants highlighted the importance of recent work around indicators of care content and quality, which concerned with the extent to which measurement methods can capture complex, multifaceted constructs. Examples of this type of validity research, which also include considerations of face and content validity of measurement approaches (e.g. scales and questionnaires), include indicators of quality of care from a woman's perspective, \[[@pone.0233969.ref078]\] from a health facility perspective \[[@pone.0233969.ref079]\] indicators of complex care processes (e.g. case management of pre-eclampsia), indicators of autonomy and respectful care \[[@pone.0233969.ref080]\] and person-centered maternity care. \[[@pone.0233969.ref081]\] Additional challenges exist with measuring quality of newborn care, starting with the data source (newborns have limited communication and if the baby is taken out of the mother's sight, she cannot report accurately). \[[@pone.0233969.ref082]\] While this work forms a large part of the current validation research of maternal and newborn health indicators, it is not yet fully formed.

Discussion {#sec013}
==========

Using mixed methods, we identified three common types of indicator validity used in the field of maternal and newborn health, all of which have a role in evaluating the performance of indicators. Key informant interviews revealed that a variety of definitions and interpretations of indicator validity exist, highlighting the need to establish a common language and understanding of indicator validity among global and local maternal and newborn health stakeholders. We have attempted to synthesize key concepts and to present a typology of indicator validity that characterizes the varied ways in which the concept of validity is understood and assessed in the literature, indicator guidance documents and by a sample of maternal and newborn health stakeholders. We suggest that those who develop, assess or recommend maternal and newborn health indicators clarify their understanding of the various types of validity of studied or recommended indicators.

Despite the importance of construct validity highlighted in key informants' responses, we identified a gap in the literature and indicator guidance documents in explicitly describing and evaluating the underlying phenomena which various maternal and newborn health indicators seek to measure, and an absence of studies of construct validity in general. For example, is the SBA indicator intended to measure an enabling childbirth health care environment, coverage of good quality childbirth care, minimum safety levels during childbirth, to be a proxy for maternal mortality, or relate to multiple constructs? Conceptual understanding of the underlying phenomena that specific indicators are intended to measure may vary across stakeholders using the indicators and may change over time, but are rarely made explicit.

There is a predominance of validation studies on the narrowest conceptualisation of validity--criterion validity--but the larger issue of the construct and its meaning for progress in maternal and newborn health is rarely addressed. Once developed, used and measured with a high uptake for many years, maternal and newborn health indicators tend to remain in use for decades. However, the constructs being measured by such indicators are often unclear or may evolve in importance over time. We also highlight a view shared by many key informants that an indicator's performance on assessment of criterion validity should not be the sole determinant of its use for monitoring and decision-making; its measurement parameters need to be "good enough" for the purpose at a given time and place. \[[@pone.0233969.ref025]\] One such aim could include generating aspirational indicator estimates for the purpose of improving quality of data or measurement methods for the future. \[[@pone.0233969.ref008]\]

There is a growing concern with the large number of maternal and newborn health indicators used across several initiatives, including the variation in indicator definitions and the resources required to produce such indicators. \[[@pone.0233969.ref006]\] A more consistent understanding of indicator validity could help guide the prioritization, development and testing of more robust maternal and newborn health indicators. \[[@pone.0233969.ref014]\] Improved global coordination among stakeholders conducting or supporting validation studies is needed to avoid duplication of efforts. Further, it is crucial to consider the perspectives of country-level stakeholders in prioritising which types of validation matter most for which indicators and which types of indicators should be validated first and where. The development of guidance and criteria for assessing common types of indicator validity, linked to an action plan to prioritize indicators for validation, could help improve such coordination. Coordinated research to assess validity of a smaller number of locally relevant core indicators that seek to measure important constructs could help accelerate action to improve maternal and newborn health. In parallel, it is also vital to coordinate assessment of indicator validity with assessment of other important attributes of indicators, including feasibility and reliability. \[[@pone.0233969.ref083]\] Studies which describe elements of clarity, feasibility and acceptability of data collection tools, \[[@pone.0233969.ref084]--[@pone.0233969.ref087]\] such as those employed in qualitative studies and cognitive interviewing, \[[@pone.0233969.ref084]\] are complementary to other assessments of validity.

Limitations {#sec014}
-----------

We used a literature review and key informant interviews to explore the field of indicator validation research in maternal and newborn health indicators. We conducted a comprehensive review of the literature published in English since 1990 to identify key themes and provide examples and acknowledge that our review may have missed relevant publications in languages other than English. We also acknowledge that while the key informants included measurement experts and authors of many of the recently conducted validation studies on maternal and newborn health indicators within the maternal and newborn health field, our sample of key informants included only English-speaking respondents working predominantly at the global level and did not include many country-level experts and stakeholders. We did not aim to summarize the findings of all validation studies for individual indicators; however, such systematic reviews and meta-analyses could be a useful next step for summarising the available evidence.

While we were informed by "multidisciplinary bodies of knowledge" which are needed for high quality conceptual frameworks, it is important to recognise that the issues surrounding validity of population health indicators are somewhat different from those of tools or questionnaires as elaborated in other disciplines, particularly psychology. \[[@pone.0233969.ref088]\] Some distinct types of validity used in these fields are not relevant to our topic and the definitions of validity we propose in this framework do not completely overlap with definitions used in other disciplines.

Conclusion {#sec015}
==========

Indicator validation is a part of a continuous process of building and synthesising evidence on indicator performance. We found that in the maternal and newborn health literature and among measurement experts, the term validity is used broadly to capture a variety of indicator performance assessments. Some of the current challenges related to harmonization and coordination of maternal and newborn health indicators stem from a heterogeneity of definitions of indicator validity, often by stakeholders from various disciplinary backgrounds. We recommend that the language used to describe validation research should be more precise as to the specific type(s) of validation assessed and the related findings (e.g. an indicator described as "valid" or "validated" should be nuanced and time- and context-specific).

In addition to the three most common types of maternal and newborn health indicator validity identified, we highlight the fact that any appraisal of an indicator's validity requires clarity about the construct that the indicator is intending to measure. We therefore recommend that future initiatives to coordinate indicator validity research focus on important underlying constructs rather than individual indicators (which represent the operationalization of constructs). This approach can help align stakeholders to develop a clear understanding of how best to measure important constructs, including agreement on "how not to measure" a construct for which "valid" indicators may not yet have been developed and tested.

Supporting information {#sec016}
======================

###### Overview of key response themes from interviews with key informants.

(DOCX)

###### 

Click here for additional data file.
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This report contains the collective views of the authors and does not necessarily represent the decisions or the stated policy of the World Health Organization.

10.1371/journal.pone.0233969.r001

Decision Letter 0

Salinas-Miranda

Abraham

Academic Editor

© 2020 Abraham Salinas-Miranda

2020

Abraham Salinas-Miranda

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

10 Dec 2019

PONE-D-19-29431

What is meant by validity in maternal and newborn health measurement? A conceptual framework for understanding indicator validation

PLOS ONE

Dear Dr Benova,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

ACADEMIC EDITOR: The paper is well-written and has adequate scientific value. However, there was a general agreement among reviewers about the need to improve the explanations of the different types of validity discussed. ​

We would appreciate receiving your revised manuscript by Jan 24 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Abraham Salinas-Miranda

Academic Editor

PLOS ONE

Journal Requirements:

1\.

When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. We note that you have stated that your data are currently in the process of being deposited . Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Additional Editor Comments (if provided):

The paper has been reviewed by independent reviewers who agree with the value of the manuscript for the readership of PLOS ONE and the important contribution to the literature. Hence, the recommendation is to accept upon minor revisions. Given the comprehensive nature of the manuscript that required diverse expertise, the Academic Editor requested more than the minumum number of reviewers and invited reviewers with different expertise (in maternal and child health, measurement, and epidemiology). The reviewers generally agreed with the need to make some changes in the manuscript, particularly related to the definition of validity and measurement validity. Please make the indicated corrections and resend a revised version.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

Reviewer \#3: Partly

Reviewer \#4: Yes

Reviewer \#5: Yes

Reviewer \#6: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: N/A

Reviewer \#2: No

Reviewer \#3: N/A

Reviewer \#4: N/A

Reviewer \#5: N/A

Reviewer \#6: N/A

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: No

Reviewer \#5: Yes

Reviewer \#6: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

Reviewer \#5: Yes

Reviewer \#6: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The topic covered by this paper is well timed, and well needed. How validity is defined, and ultimately what should be considered a valid maternal and newborn health indicator is important. As such, the paper has potential to provide much needed guidance in the field, and help to focus the 140+ MNCH indicators currently in play.

However, the authors would benefit from setting the stage early of what is meant by validity, and if they intend to also talk about reliability. This would mean a thorough (though concise) review of the definitions of validity, anchored with multiple strong referrences published in peer reviewed journals or text books. This will help readers also know what to look for when reading the author\'s results, and may help the authors taylor the way they present their results, key points they highlight, and what they ultimately discuss. There are a couple of types of validity - namely face validty, and content validity, both important, that are missing. 
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Overall on the analysis, since all data was qualitative, it would be useful to highlight key points with an occasional quote, if possible, or demonstrate a sense of whether or not certain opinions are those of only one person or multiple people. Key informants do not seem to contribute much to the discussion of criterion or convergent validity, though it would strenghten the study to integrate a bit more from Key informants on these topics.

This paper has immense potential. I hope these observations are useful.

Reviewer \#2: The paper presents an important perspective on how validity of maternal and newborn indicators can be defined and understood. This is important especially considering that the definitions and data sources used to produce indicator estimates vary and challenges exist with completeness, accuracy, transparency, and timeliness of data in many LMICs. Generally, the paper is well written and a few points to consider are as below:-

Introduction:

\- Well summarized including the global and regional burden of the problem highlighting LMICs.

\- References used are up-to-date

Materials and Methods:

\- Overall good structure followed

\- Interviews were conducted by one interviewer between December 2017 and November 2018. Were the interviews conducted face-to-face, by telephone or skype?

\- One interviewer conducted the data collection from the 32 participants over a period of time. Can the authors indicate why recording the interviews was not opted for, yet it is an easier and faster way of collecting qualitative interviews and minimizes recall bias from the interviewer perspective? In addition, it would be nice for the authors to summarize the backgrounds of the participants interviewed.

\- Only one interviewer did the conducted and performed the shorthand note taking between 45 -- 90 minutes. How was this structured?

\- How was the data from the 32 interviewees analysed? There is no analysis plan in the manuscript.

\- Ethics -- data collected involved interviewing human subjects on the subject matter. Why was ethical approval not sought by the authors?

Results and Discussion

\- Authors have reported the results in a good style with sub-headings separating the various aspects.

\- It is important that the authors highlighted the issue of subjectivity in the acceptable levels of validity in the criterion and convergent validity.

\- Main points have been well summarized in the discussion section

References

\- Robust review of literature done

\- Authors to review references 1,2,4,17,19 and 24 to include the URLs/web links and access dates as these are online/electronic sources as per the recommended citation style.

Reviewer \#3: The topic addressed is an important area in which some confusion is common, in general, ie not limited to maternal health. So, this manuscript has potential to make a useful contribution to help clarify issues within this field. However, there are two aspects which I think need improvement to strengthen this work:

i\) the three types of validity discussed belong within an established theoretical framework. I recommend that this be acknowledged more explicitly, by providing the definitions of these in the introduction rather than in the results, perhaps with a little more reference to the diversity of types of validity considered in literature.

ii\) The methods indicate that a literature review was conducted (line 117). Although the methods for identification of literature are stated (lines 131-8) the results provide very limited information regarding the literature identified, not even the number of manuscripts identified is mentioned. It is for this reason that I have indicated that all data underlying finding are not made fully available. More details on the findings should be provided.

Other minor matters for attention:

Line 169 - refers to S2 Table, but I could not locate it

Line 186 -- surely multiple measurements need to be compared with the relevant 'gold standard' measurements to examine criterion validity.

Lines 192-3 - please clarify how the statement is related to the concept of convergent validity.

Lines 247-50 - examples are useful but please provide a methodological reference for lines 247-8.

Lines 223-5 - this statement does not appear to be supported within the examples provided in Table 1.

Line 303 - more detail of the indicator needs to be provided: birth attended by ? Are lines 303-4 referring to source 58 or to the interviewees of the reported study?

Lines 341-3 - several potential uses of the indicator are mentioned. It is however unclear why the discussion seeks to align the indicator with only one use, when in fact it may fulfil each of the stated uses in differing contexts.

Lines 353-5 - the intended meaning is unclear.

Line 479 - journal details for ref \[26\] need to be corrected.

There are a number of occurrences of the term 'this paper', some of which could be dropped.

Tables and Figures

I found it confusing that text refers to Tables and Figures, but they are entitled Tabs and Figs

It is unclear what is plotted in each sub-plot in Figure 2 -- what do the two axes represent? In line 206 reference to hitting the bullseye is confusing since the plot for high validity and low reliability has points scattered around the bullseye but spread across the entire circular region.

In table 1 the headings could be clearer, eg in the second column the content is: "Indicator: gold standard / setting (study/ies"); since impact indicators are reported to be less common it is surprising that they appear first in the table.

In Table 2 the definitions of predictive values are too narrow: these terms are used within diagnostic assessments and thus revolve around a test providing a result rather than an individual reporting something. Additionally the definition for AUC does not actually state how AUC is derived, it focuses more on the definition of the ROC (receiver operating characteristic) curve.

Table 3 -- the text indicates that it is about indicators in population-based surveys. This should be reflected in the title of the Table.

Table 4 provides limited details about the data used and the methods of comparison. For example for Caesarean section the source reference uses both coefficients obtained using linear regression, for multiple studies, and also provides a scatterplot which displays the data. By contrast for RMNCAH is for just one study and each of the four methods of estimation for a number of indicators are reported, which enables simple differences to be derived, though they are not actually derived.

Reviewer \#5: Thank you for the opportunity to review the manuscript.

The authors should be congratulated on a well-written and timely paper presenting a range of perspectives on how validity of maternal and newborn indicators is defined and understood by those who develop and use these indicators. The study has important implications for ongoing global efforts to track maternal and newborn health progress. Please see below for specific comments on the manuscript:

Materials and methods

• Line 117: Please reference the key indicator guidance documents used in the review.

• Line 22: Can the authors please provide further details about the key informants' backgrounds/expertise on this topic or in MNH? The authors provide some background information in the limitations section of the discussion however it would be useful to have this outlined earlier. Were all key informants' part of the MoNITOR group?

• Was there any pre-testing of the interview guide prior to the 32 key informant interviews?

• What was the consent process?

• Reference 23: Is this paper accepted for publication or under review? Please update reference.

• Line 127: What written materials and relevant publications were received from the respondents after the interview? How were these relevant to the interviews?

• Can the authors please clarify the process for the qualitative data analysis? Apologies if I have overlooked this. Was the analysis undertaken by the same person who undertook the interviews?

Results

• Line 223: The authors state that key informants noted that a substantial portion of recent work on assessing criterion validity has focused on indicators of care coverage. It would be useful to know what proportion of the key informants identified this to be the case.

The discussion is well-written, and the conclusion is concise and logical. This is an interesting and useful paper that should be considered for publication following revision of comments.

Reviewer \#5: Review Comments

This is a very interesting article; however there are some aspects that need to be incorporated in some sections in order to improve the manuscript and comprehension, especially regarding methods. A more detailed descriptions in some sections are required.

Reviewer \#6: Review Comments

In general terms, the present study aims at gathering concepts and themes essential when analysing indicator validity in the context of maternal and newborn health indicators with the goal of reaching high health standards of these two population groups. Personally, I believe the main subject of this original body of work made a substantial contribution in presenting the existing knowledge about indicator validity through a qualitative investigation based on interviews to key informants, literature revision and which had the participation of the MoNITOR group. The results of the investigation are a tool that will allow all stakeholders in maternal and newborn health to reconsider the ongoing work about indicator validity. This work will improve long- term health of pregnant women and their newborns who are a vulnerable group through their life course.

Introduction:

In this section, reference is made to the background and settings in which this work is developed, objectively contributing to filling the information gap existing when discussing indicator validity in maternal and newborn health. Consequently, the objective of this study was clearly stated in this section.

I suggest reviewing the content in parentheses in line sixty-eight.

Materials and methods:

This section includes an organized structure in which the study design, sample and type of sample for the selection of key informants are stated. It also explains, in detail, the terms used to conduct the review and it sets the limits of maternal and newborn health indicators. Moreover, it incorporates a definition of concepts.

Since this work was developed in four stages, I suggest mentioning the four stages in the first paragraph of the section. I also suggest, moving the interview to key informants to the beginning adding that the interview is part of a qualitative study which main result and methodology were already published. Then, I would list the review and MoNITOR group discussion. I give this advice considering that is the way the rest of the section is organised.

The second paragraph begins with the type of sample used to select key informants and, even though it is indicated that the first results of these interviews were previously published in another study, I think it is necessary to add the main details of the methods of such work in this section of this study.

Ethics Approval:

I suggest adding, at the end of Materials and Methods, ethical aspects of the study, such as whether the researchers had informed consent of key informants and why they did not present the protocol before the ethics committee.

Results:

The results are in accordance with the objects of the study, but in the case of the review the results are not complete because they do not inform the number of studies obtained through the research nor the studies selected. I suggest completing with these pieces of information.

The first paragraph of this section mentions Table S2 (line 168), but in the annexed material there is only a Table S1. Line 297 mentions S1, I suggest checking if this Table is indeed Table 1.

Discussion:

This section discusses the study's main results. Some aspects are discussed in the section Results, for instance, when limitations of the use of the denominator in indicator validity are mentioned.

Conclusion:

It focusses in the objectives of the study, highlighting the main recommendations of the study.

Bibliographic references: 
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• Standardize the name of the journals. Some journal´s names are written completely and others, abbreviated.

• Please, be sure you have the publication tittle name of all your citations, not only the link, and the date of access.
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Hi Lenka,

Apologies for the delay (it looks like the previous handling editor became unavailable and your manuscript was without an editor for some time before it was assigned to me, but I\'ve tried to accelerate this round of review and believe the last revisions should be relatively quick!).

This paper is very comprehensive, and an important analysis of the types of indicators available.

There are only some additional minor comments from two reviewers to address. In addition, if you could address the following, that would be helpful.

-Can you specify who the key informants were. I know there is reference to another paper will full methods, but it would be good to summarize in a sentence or so here.

-Can you clarify if no ethical approval was sought, or if it was exempted because considered to be non human subjects research? The paper includes a quote, so even though it\'s not sensitive personal information, many ethical review boards would want to review a protocol that includes interviews.

This is completely discretionary if you want to address in the discussion at all since you want to include both maternal and newborn health measurements, but because of my work on trying to measure experience of care for newborns (<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445465>), I\'m always aware of the additional challenge with measuring newborn quality of care because of who is reporting (if the baby is taken out of the room, the mother can\'t report and the health worker may not record etc etc.) since newborns have limited verbal communication as opposed to measures for women who can self-report.

Thanks so much.
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